Clinical Trial

Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.

Name: Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib. — clinical trial record (NCT07645430)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Alopecia

Completed

View on ClinicalTrials.gov →

Summary

The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.

Trial Details

NCT Number	NCT07645430
Lead Sponsor	Benha University
Conditions	Alopecia Areata
Enrollment	20 participants
Start Date	2023-01-01
Primary Completion	2024-01-01 (estimated)
Study Completion	2026-06-09 (estimated)
Updated on ClinicalTrials.gov	2026-06-12